Kalaris therapeutics incKLRS.US Overview

US StockHealthcare

(No presentation for KLRS)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

KLRS Overall Performance

KLRS AI Analysis & Strategy

KLRS Recent Performance

2.36%

Kalaris therapeutics inc

0.81%

Avg of Sector

-1.14%

S&P500

KLRS PowerScanner

KLRS Key Information

KLRS Valuation Metrics

KLRS Earnings Table

KLRS Profile

Kalaris Therapeutics Inc operates as a pharmaceutical company. The Company specializes in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems.